Quick answers
- What is Trudhesa?
- Trudhesa is a brand name of Dihydroergotamine mesylate, a prescription medicine. The FDA NDC Directory lists 1 Trudhesa product in 1 strength and form.
- Who makes Trudhesa?
- Impel Pharms holds the FDA application for Trudhesa (NDA213436, approved September 2, 2021).
- Is there a generic or store brand of Trudhesa?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Trudhesa product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Trudhesa been recalled?
- No recall linked to Trudhesa products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Trudhesa is
Each Trudhesa product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Dihydroergotamine mesylate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dihydroergotamine mesylate 4 mg/mL spray, metered (nasal) | Trudhesa | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dihydroergotamine mesylate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA213436 | Impel Pharms | September 2, 2021 | 1 |
Companies that list Trudhesa
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Trudhesa products.
- Impel Pharmaceuticals LLC1 product
Recalls
No recall linked to Trudhesa products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.